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Abstract
Between August 2012 and April 2013 the Career Development Fellowship programme of
the Special Programme for Research and Training in Tropical Diseases (World Health
Organization) underwent an external evaluation to assess its past performance and deter-
mine recommendations for future programme development and continuous performance
improvement. The programme provides a year-long training experience for qualified
researchers from low and middle income countries at pharmaceutical companies or product
development partnerships. Independent evaluators from the Swiss Tropical and Public
Health Institute and the Barcelona Institute for Global Health used a results-based method-
ology to review the programme. Data were gathered through document review, surveys,
and interviews with a range of programme participants. The final evaluation report found the
Career Development Fellowship to be relevant to organizers’ and programme objectives,
efficient in its operations, and effective in its training scheme, which was found to address
needs and gaps for both fellows and their home institutions. Evaluators found that the pro-
gramme has the potential for impact and sustainability beyond the programme period, espe-
cially with the successful reintegration of fellows into their home institutions, through which
newly-developed skills can be shared at the institutional level. Recommendations included
the development of a scheme to support the re-integration of fellows into their home institu-
tions post-fellowship and to seek partnerships to facilitate the scaling-up of the programme.
The impact of the Professional Membership Scheme, an online professional development
tool launched through the programme, beyond the scope of the Career Development Fel-
lowship programme itself to other applications, has been identified as a positive unintended
outcome. The results of this evaluation may be of interest for other efforts in the field of
research capacity strengthening in LMICs or, generally, to other professional development
schemes of a similar structure.
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Author Summary
The asymmetry of research training between high and low and middle income countries
(LMICs) and the resulting need for research capacity strengthening (RCS) in under-
resourced regions has long been established. In 1999, the World Health Organization
(WHO), through the Special Programme for Research and Training in Tropical Diseases
(TDR), launched the Career Development Fellowship (CDF) programme, in which
LMICs’ candidates spend one year in a pharmaceutical company to be trained in product
development and clinical research and then return to their home institution. Between
August 2012 and April 2013, the programme underwent an independent external evalua-
tion from the perspectives of relevance, effectiveness, efficiency, and impact, and sustain-
ability. In addition to analysis of data and documentation, programme managers, current
and former fellows, home and host institutions participated in the evaluation through sur-
veys and interviews. In the current article, the external evaluators, along with CDF pro-
gramme managers, discuss the results of the evaluation in the broader context of
individual and institutional RCS, underlining CDF successes, including transmitting
essential skills and networks, and addressing the challenge and fundamental importance
of integrating fellows, home and host institutions into an on-going relationship that solidi-
fies and amplifies the benefits of the one-year experience.
Introduction
The gap in research capacity strengthening (RCS) has been widely recognized as a major stum-
bling block for development in low and middle-income countries (LMICs) and is manifested
in the absence of trained and experienced candidates with skills, knowledge, networks, and
confidence to build careers in research [1–3]. Both cause for and consequence of this deficit in
RCS is the phenomenon called ‘brain drain’: young skilled candidates for a research career go
abroad to find better research environments and working conditions. Hence, this continuing
exodus to industrialized countries results in reduced numbers of trained scientists in LMICs
[4]. This is observable also in health-related research areas where LMICs continue to lag behind
industrialized countries although in these very places key improvements in public health stand
to be achieved through evidence-based clinical research.
Founded to promote high-quality clinical research in LMICs, the Career Development Fel-
lowship (CDF) programme began in 1999 as a partnership between the World Health Organi-
zation Special Programme for Research and Training in Tropical Diseases (WHO/TDR) and
one pharmaceutical company [5]. During the initial phase of the programme (1999–2009),
WHO/TDR awarded one fellowship per year to nine candidates originating from seven
LMICs. The fellows were all placed with GlaxoSmithKline Biologicals, the Belgium-based divi-
sion of the global vaccine and pharmaceutical research, development, and production com-
pany. This early phase (Phase I) assisted WHO/TDR to identify and develop appropriate
procedures and mechanisms to support and administer the fellowship programme. In the sec-
ond period (Phase II—2008–2013) a grant from the Bill & Melinda Gates Foundation enabled
WHO/TDR to scale-up the programme over a four-year period and to engage the participation
of additional pharmaceutical companies and product development partnerships (PDPs) as
host institutions. An overview of fellows awarded throughout the programme period 1999–
2013 is provided in Table 1.
The CDF programme provides qualified scientists from LMICs with three core supports: (i)
a grant that covers the administrative costs of the fellowship, including attendance at one
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and PL were not involved in any evaluation criteria
settings or reporting statements.
professional scientific meeting during fellowship; (ii) a 12-month assignment in the clinical
department of a pharmaceutical company or PDP (including necessary training resources such
as clinical supervision and mentoring); and (iii) an annual face-to-face alumni meeting and
networking opportunities through a dedicated career development website [6]. The pro-
gramme addresses the research fields of product development (PD) and clinical trials (CT),
which are not widely taught at academic centres. Between 1999 and 2012, at the time when the
evaluation was launched, 27 fellows had completed this unique programme, which facilitates
the development of career elements essential to becoming a leader in clinical research. The pro-
gramme’s ultimate goal is for fellows to return to their home institutions equipped with special-
ized skills, experience and access to vibrant networks within the international research
community. Fellows benefit their home institutions and, by extension, their home countries, by
pursuing high-level research careers and influencing their local environments.
As part of the TDR framework for performance assessment [7], two institutions–the Swiss
Tropical and Public Health Institute (Swiss TPH, Basel, Switzerland) and the Barcelona Insti-
tute for Global Health (ISGlobal, Barcelona, Spain)–were commissioned to undertake an exter-
nal and independent evaluation of the WHO/TDR CDF programme, “to evaluate the outcome
and potential impact of the project in order to provide the evidence to assist on recommenda-
tions and future decision making.” This article summarizes the approach and results of the
evaluation, and indicates how the programme could be adapted in the interest of further scal-
ing-up and extension. Similar initiatives may benefit from the experience of the CDF
programme.
Methods
Approach
In order to assess the WHO/TDR CDF programme in its various aspects, the evaluators
employed a results-based monitoring and evaluation approach [8]. This encompassed an initial
assessment of inputs, examined activities and outputs, and culminated in a review of outcomes
and impact, for which indicators were defined. The evaluation was designed to assess the pro-
gramme from the following four perspectives: i) Relevance: Does the CDF programme address
relevant challenges, needs, and gaps for fellows and their home institutions and countries?; ii)
Effectiveness: Does the programme deliver training and capacity development effectively?; iii)
Table 1. Overview of fellows awarded throughout the programme period 1999–2013. Altogether, 43 fellows were selected, however, for one fellow it
was impossible to obtain visa. Hence, 42 were successfully placed, one withdrew due to conflict with supervisor at the host institution, and one was unable to
return to home institution. Numbers of fellows for the period 1999–2013 sum up by the numbers indicated in bold, the years 2009–2012 are also shown as
breakdown in light print. At the time of the evaluation, starting from August 2012, 27 fellows had completed the CDF programme.
Period of
time
Number of fellows
selected
Gender ratio
(m/w)
Fellowship
completed
Fellowship not
completed
Reintegration
successful
Reintegration not
successful
1999–2009 9 8/1 9 0 9 0
2009–
2010
7 6/1 7 0 6 0
2010–
2011
4 3/1 4 0 4 0
2011–
2012
7 6/1 6 1 7 0
2009–2012 18 15/3 17 1 17 0
2012–2013 15 7/8 15 0 14 1
Summary:
1999–2013 42 30/12 41 1 40 1
doi:10.1371/journal.pntd.0004631.t001
Evaluation of the TDR CDF Programme
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004631 May 25, 2016 3 / 13
Efficiency: Does the programme implement its activities in an efficient manner?; and iv)
Impact and Sustainability: Has the CDF programme contributed to developing clinical research
and product development capacity for LMIC researchers, institutions, and countries, and will
it continue to do so?
Log frame
A log frame was developed encompassing the four aspects discussed above, including detailed
descriptions and objectives for each of the dimensions to be evaluated, outputs and/or out-
comes, and defining indicators and data sources (Table 2). This log frame underwent several
rounds of external review and refinement before the development of evaluation tools used to
collect data from programme participants.
The initial evaluation design was hampered by the fact that benchmarks had not been estab-
lished at the outset of the CDF programme, i.e. the “training needs” for home institutions’ pur-
poses or “training gaps” of fellows. These baseline indicators could only be included in the
evaluation as retrospective assessments by the survey participants. For this, the evaluation
team developed prelisted ranges of possible bottlenecks, gaps, or professional activities for the
persons filling in the survey to select from, with the opportunity to add others in free text. For
instance, the evaluators surveyed fellows regarding their pre-fellowship skills and knowledge
through a questionnaire.
Sources
Open access TDR documentation and relevant websites as well as internal documents provided
by CDF management served the evaluation team as written sources. The following groups of
people involved in the programme were addressed in different ways: (i) the CDF management
team at WHO/TDR, (ii) representatives of home institutions, (iii) representatives of host insti-
tutions, and (iv) fellows.
Using the log frame, three versions of a comprehensive questionnaire were developed to be
administered to representatives of home institutions, host institutions, and fellows in order to
retrieve information about various aspects of the programme from multiple perspectives
(Table 3). Based on both the log frame and survey results, four versions of a focus group discus-
sion catalogue were developed, one for each of the three surveyed groups and an additional one
for CDF management.
Interviewees
An attempt was made to contact and invite all home institution, host institution, and fellow
participants in the programme to participate in the evaluation (27 fellows, 16 host institution
representatives, 25 home institution representatives, Table 4). Out of those successfully
Table 2. Main areas of the programme covered in the evaluation log frame.
Strategy and management
Communication and marketing
Recruitment and selection process
Fellows’ learning experience
Relationship between host companies, fellows, home institutions, and CDF management team
Reintegration of fellows into their home institutions
Roles and responsibilities of the various stakeholders
Experiences and outcomes for the various stakeholders
doi:10.1371/journal.pntd.0004631.t002
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contacted, a fairly good response rate was achieved from programme fellows (about 78%).
Host institution representatives were somewhat less responsive (56%). Responses from nine
out of sixteen representatives gave perceptions ranging from critical to enthusiastic, as mir-
rored in the participation in the alumni meetings. In contrast, such diversity of views could not
be obtained from representatives of home institutions where only three out of ten responded.
The low response rate from home institution representatives (12%) was likely due to the lack of
a specified focal person for the CDF programme or to the original programme liaison no longer
being available. We must consider that results drawn from the home institution group may be
biased in the sense that the ones complying were possibly the mentors most involved in the
programme. However, this fact strongly left its mark in the recommendations for the pro-
gramme’s future regarding the involvement of home institution representatives.
Procedure
The evaluation was carried out between August 2012 and April 2013 and covered the pro-
gramme from 1999 through 2012. In a first phase, documents were screened and the log frame
developed, after which the CDF management team was interviewed to refine the evaluation
strategy. Following a piloting phase, questionnaires were administered to the three participant
groups. Analyses were followed by in-depth focus group discussions and interviews with repre-
sentatives from all three groups and the CDF management team before the final report was
drafted.
Questionnaires were administered online. The surveyed groups were adequately informed
of the procedures, and general and personalized reminders were delivered in a timely manner.
Quantitative responses were collected and compiled to inform the next phase of the evaluation,
which included an in-depth analysis of survey results in order to determine which aspects of
the programme would be qualitatively addressed through stakeholder interviews.
Preliminary and final results were discussed with all stakeholders involved (including the
donor organization and CDF management) via telephone interviews and in-person meetings,
and were presented during the third CDF programme alumni meeting. Results and recommen-
dations from the evaluation were translated into a reporting document that was presented on
Table 3. Elements addressed in the questionnaires.
Admission process
Relevance to individual and institutional needs
Effectiveness in developing fellows’ research capacity
Fellows’ absence, return, reintegration, and impact
Roles and responsibilities
Programme management
Online resources
Long-term effect on collaboration and sustainability
doi:10.1371/journal.pntd.0004631.t003
Table 4. Responsiveness of programme participants to the survey.
Participants Number who responded to survey Number successfully contacted for survey Total number
Fellows 21 27 27
Host companies’ representatives 9 16 16
Home institutions’ representatives 3 10* 25
*In some cases contact person information was not available or was no longer correct, in other cases there was no focal person or coordinator to contact.
doi:10.1371/journal.pntd.0004631.t004
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various occasions from a ‘lessons learned’ standpoint. Results of the evaluation are also briefly
described on the TDR website [9].
Results
Relevance
The CDF programme exemplifies all elements included in TDR’s mission statement, mandate,
and objectives. It is consistent with TDR’s strategic commitment to develop innovative knowl-
edge, solutions, and implementation strategies on health needs [10–12], and translates these
concepts into practice. The CDF scheme supports evidence-based decisions and so contributes
to the development and implementation of new or improved interventions as well as to the
translation of innovation, knowledge, solutions, and implementation strategies to policy and
practice in addressing development goals and improving health in disease endemic countries.
Applicants to the programme and the fellows selected fall into the scope of the programme
based on their scientific backgrounds. Fellows originate from target countries and regions (Fig
1). Programme participants are placed at host institutions that contribute to the goals stated in
the programme.
Fellows surveyed identified major bottlenecks for their home institutions and reported
whether they were, in their view, addressed by the CDF programme (Table 5). Twelve persons
Fig 1. Distribution of fellows’ home countries and host institutions during the Career Development Fellowship (CDF) Programme between 1999
and 2012.Data Source:World Health Organization. Map Production:WHOGraphics. The boundaries and names shown and the designations used on
this map do not imply the expression of any opinion whatsoever on the part of theWorld Health Organization concerning the legal status of any country,
territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate
border lines for which there may not yet be full agreement.
doi:10.1371/journal.pntd.0004631.g001
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(57%) estimated that the CDF programme addresses the bottlenecks of home institutions well
or very well. The fellows’ placements were–through joint efforts–good matches between the
needs of the fellows’ home institutions and the fellowship opportunity offered by the host com-
pany. In consequence of this perfect fit strategy, and due to a preference for high quality over
quantity of participants, some CDF programme fellowship positions were not filled.
Home institution representatives stated that the CDF programme led to alleviation of insti-
tutional scientific isolation, mainly through the networking aspect of the programme, which
facilitates long-lasting relations through post-training communication and collaboration on
several levels: between fellows, between fellows and their host institutions, and between fellows’
home institutions and the developing CDF programme network.
Bottlenecks identified by host companies encompassed institutional staff knowledge (8/9),
project management ((7/9), and lack of collaboration with other institutions/companies (6/9).
Host companies’ representatives reported–similar to the fellows’ perceptions–adequate target-
ing of the CDF programme to existing bottlenecks, both to theirs and the ones of the fellows. In
addition, they valued the programme’s contribution to improving both “administration” and
“documentation” higher.
Taken altogether, the evaluation found the CDF programme to be highly relevant with
regard to TDR objectives and the programme’s own stated objectives.
Effectiveness
The training components covered by the various fellowship placements include i) scientific
knowledge (clinical pharmacology, good clinical practice, good laboratory practice, biostatis-
tics, microbiology/molecular biology, medicine and clinical trial design), ii) technical skills
(project planning and management, evidence-based study implementation, ethics and ethical
clearance, regulatory compliance, monitoring and evaluation, quality control, meeting organi-
sation and presentation), and iii) cross-cutting skills (see below).
Table 5. Fellows (n = 21) identified major institutional bottlenecks and assessed the programme’s contribution. Bottlenecks were prelisted, with an
option to add others in freetext.
Bottlenecks to the institution and
country
Identiﬁed by # of
fellows
Identiﬁed by % of
fellows
Addressed by programme
according to # of fellows
Addressed by programme
according to % of fellows
Funding 17 81 3 14
Facilities/Infrastructure 14 67 3 14
Staff knowledge/Capacity 14 67 15 71
Lack of collaboration with other
institutions/companies
13 62 9 43
Lack of shared knowledge 11 52 7 33
Regulatory issues 10 48 7 33
Proposal development 9 43 10 48
Generating new ideas 8 38 5 24
Project management 8 38 8 38
Proposal writing 8 38 9 43
Administration 6 29 1 5
Documentation 6 29 3 14
Lack of analysis 4 19 1 5
Dissemination of results 3 14 0 0
Other cross-cutting skills 2 10 1 5
doi:10.1371/journal.pntd.0004631.t005
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CDF participants emphasized the following as major successes of the programme: i) a prac-
tical approach to addressing research skill needs on the scientific, technical, and cross-cutting
levels; and ii) the involvement of the fellow in a wide range of professional activities through a
strong link to the host company and to a larger international research network.
Mirroring the fellows’ individual research capacity needs, the pre-training gaps identified
are summarized in Table 6. More than 90% of fellows reported that their skills and competen-
cies in product development or clinical trials were either better (29%) or much better (62%) fol-
lowing their participation in the fellowship. The hands-on experience provided was highly
valued. When asked whether they would prefer more theoretical training or more hands-on
experience, 76% of the fellows chose the latter.
In addition to scientific skills, fellows reported considerable improvement in cross-cutting
skills such as (in %): study implementation (90), regulatory issues (90), documentation (86),
monitoring & evaluation (81), project planning (81), management and leadership (76), prob-
lem-solving (71), quality control (67), ability to acquire new knowledge (62), collaborative
practice (62), administration (57), social networking (48), and evidence-based implementation
(38).
The networking aspect of the CDF programme was brought forward through three plat-
forms, i) the online platform and ii) the alumni network, and iii) alumni meetings.
Initially developed as a communication platform site for fellows and launched under the
name “Continuing Professional Development”[13], the online portal became crucial for pro-
gramme participants. It soon evolved into a career development tool now known as the Profes-
sional Membership Scheme (PMS), which all fellows are invited to join. It was built in
partnership with WHO-TDR in order to capture the development of core competencies as cur-
rent and former fellows progress through their careers. The PMS is now embedded in the
Global Health Network [6], a virtual professional community comprising a collection of inter-
connected specialist research sites linked through a digital hub, much like an online science
park. Its success was one of the positive unintended outcomes from the CDF programme noted
by the evaluation team. During the period from mid-October 2012 to mid-June 2013, PMS
web pages received an average of 25 unique visits and 248 views per month from various stake-
holders. Fellows reported that some of the most important uses of the website are networking
(64%), retrieving programme information (64%), and searching for advanced training options
(36%). Interestingly, 58% of fellows reported that the alumni network helps them to alleviate
scientific isolation. Growing attendance at the annual CDF alumni meeting, which brings
Table 6. Fellows (n = 21) identified individual pre-training gaps in skills and competencies and
assessed the programme’s contribution. Gaps were prelisted, with an option to add others in freetext.
Personal pre-training gaps Identiﬁed by
fellows [number
(%) of fellows]
Addressed by
programme
[number(%) of
fellows]
Project management 17 81 20 95
Trial design 12 57 17 81
Clinical pharmacology 11 52 7 33
Good Clinical Practices / Good Lab Practices 10 48 18 86
Biostatistics 7 33 7 33
Microbiology or molecular biology 6 29 2 10
Ethics 4 19 17 81
Medicine 1 5 2 10
doi:10.1371/journal.pntd.0004631.t006
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together CDF management, fellows and both host and home institution representatives, may
be seen as an indicator of increased networking activity (Table 7).
Taken together, the results show evidence that the CDF programme delivers the intended
training and capacity development in an effective manner.
Efficiency
A clear measure of the efficiency of the CDF programme was the successful transition from
Phase I to Phase II and the expansion of the programme to include more fellows, host compa-
nies, and home institutions from LMICs. Activities were implemented efficiently. In general,
programme deadlines were met, although delays caused by external factors like visa application
procedures and contract processes in companies, were seen in all recruiting rounds. The selec-
tion process was identified as very transparent by all stakeholders involved. Each round of
selection has seen more eligible applications (minimum double) than positions offered. CDF
management has opted for quality in each round, leaving positions empty rather than accept-
ing fellows that are not optimal matches. The support and flexibility of host institutions to
facilitate the integration of the fellows, both at the cultural and working levels, is noteworthy.
Once training placements are over, a smooth reintegration of fellows is necessary in order
for LMIC-based home institutions to reap the benefits of the CDF programme. However, 38%
of fellows reported that their reintegration was “problematic,” and three fellows reported that
problems with re-entry were not resolved, despite the initial agreement between home institu-
tions and TDR to reintegrate fellows at least at their previous level of employment. Such find-
ings emphasize the home institution stakeholders’ crucial role as participants and supporters of
the fellowship programme in order for it to sustain long-term impact.
Impact and sustainability
This evaluation reviewed the short-and mid-term impacts of the CDF programme. There were
three major indicators for impact: (i) enhancement of research/scientific activities; (ii)
improvement in research environment at institutional and national level; and (iii) engagement
in high-level scientific collaboration. The indicators include the amount and quality of fellows’
training, research, and networking activities; number of publications and conferences; and
involvement in PD and CT post-training.
A crucial assessment of the impact and sustainability was the involvement in high-level sci-
entific activities towards the end of and after the CDF fellowship period. The data in Table 8
suggest that fellows are equipped with skills for leadership and an ability to conduct projects in
an international context. An interesting aspect to highlight is the level of involvement of fellows
in national and international collaborations both during (52%) and after (81%) the training
period.
Anecdotal (at this stage) cases showed that sustainability was supported best when home
institutions gave a high level of attention to the post-training reintegration period of their
Table 7. Attendance at CDF alumni meetings.
Attendance at CDF Alumni Meetings
Year % of former fellows % of host companies*
2010 90,5 (19/21) 50 (9/18)
2012 96,3 (26/27) 69 (11/16)
*host companies were not reimbursed to attend the alumni meetings from the programme funds
doi:10.1371/journal.pntd.0004631.t007
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fellow. Also, first evidence indicates an important role of the home institution key persons
towards harmonized communication between fellows, host, and home institution personnel.
So far, the CDF programme has contributed to developing PD and CT capacity for LMIC
researchers, institutions, and countries, and has made good progress towards strengthening
research capacity.
Recommendations
The evaluation highlighted the following general recommendations: i) continue and expand
the CDF programme, ideally in partnership with other research organisations with similar sup-
porting objectives; ii) develop a reintegration process that includes a re-entry grant scheme,
overlapping fellows at host companies, and securing academic credit for programme participa-
tion; and iii) involve home institutions, primarily by better understanding and defining the
roles and responsibilities of the different stakeholders in the CDF programme.
Discussion
One fundamental cause of LMIC’s limitation in terms of clinical research remains the insuffi-
cient number of experienced researchers with: i) necessary knowledge and skills, ii) access to
scientific networks, and iii) the confidence to design and lead their own research programmes
[14]. The present external evaluation found that the CDF programme, as designed, enables fel-
lows to acquire essential knowledge and skills. Many fellows reported that their skills and com-
petencies for PD and CT are (much) better following the fellowship, and that the hands-on
training they received was critical for their career development.
Table 8. Participation of Fellows (n = 21) in professional activities. Since we lack pre-training data these
results cannot be viewed as evidence of professional advancement attained through the CDF programme.
Professional activities were prelisted, with an option to add others in freetext.
Professional activity number of
fellows
% of
fellows
Participation in PD/CT Projects
Submission of at least one protocol for ethical approval 14 67
Participation in at least one clinical trial 13 62
Participation in at least one PD project 10 48
Participation in a leading role in at least one PD/CT project 9 43
Participation in Grant Applications
Participation in at least one international grant application 12 57
Participation in at least one national grant application 3 14
Receiving a Grant
Received an international grant 7 33
Received a national grant 2 10
Dissemination of Results
Established additional national or international research
collaborations after completion of training period
17 81
Submitted at least one manuscript for publication 15 72
Participated in a national or international meeting or conference
related to PD/CT
14 67
Established additional national or international research
collaborations
12 57
Had at least one publication 9 43
doi:10.1371/journal.pntd.0004631.t008
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However, other institutional-level factors such as: i) research infrastructure, ii) the transla-
tion of individual capacity into institutional research capacity strengthening, and iii) an envi-
ronment that allows trained researchers to stay in or return to low and middle income home
countries, remain key [2, 3, 15]. The CDF programme stipulates the return of fellows to their
home institution for at least one year after completion of the fellowship period. All but one (at
the time of the submission of the manuscript, 41 fellows had completed their fellowship,
Table 1) were able to comply with this stipulation. Similar findings have been made for the
majority of other TDR postgraduate grantees [16]. The evaluation found that the programme
has created a context that enables former fellows to build on their network of peers, mentors,
and supervisors. As such, the CDF programme is surely not contributing to ‘brain drain’.
Through the evaluation, it became clear that the home institution has a central role in ensur-
ing successful reintegration. It is the responsibility of home institution representatives to pro-
vide an appropriate environment in which returning fellows can share their new skills. The
rather low percentage of fellows who reported improvement in evidence-based implementation
is of concern, emphasizing the crucial role of the home institution. In cases where home insti-
tutions valued the return of their fellow as an opportunity to develop their institutional, local,
and national research environment, they were able to successfully translate the individual fel-
lowship into sustainable RCS. It is, however, the fellows’ responsibility to commit to sharing
what they have acquired through the fellowship: experience, expertise, methods and tools,
teaching skills, contacts, and networks.
The fellowship experience does not end upon return to a home institution. On the one
hand, regular alumni meetings allow CDF programme peers and mentors to meet. On the
other hand, the web-based portal is continuously and increasingly being utilized, particularly
following its evolution into the PMS (embedded in the Global Health Network and used by
many professionals in health-related research and development), through which relevant
career competencies can be documented and displayed. Rooted in, but grown beyond applica-
tion within the CDF programme only, the PMS was revealed by the external evaluation as an
unintended outcome that heavily contributes support to CDF alumni and, beyond, to the inter-
national clinical research community. Above all, both the personal and work-related contacts
between fellows and host institutions made through the programme prove to be major sources
for continued and future collaborations (for 57% of fellows) across disciplines and sectors,
nationally and internationally. Surely, capacity-building approaches are most promising when
driven by the spirit of shared responsibility and guiding principles shared by donors and part-
ners from different sectors in the North and South [5, 17–20].
The period (post-2013) following the independent evaluation of the WHO/TDR CDF pro-
gramme, has seen considerable progress. With regard to the successful reintegration of fellows,
a three-step strategy has been developed including: (i) define clear responsibilities, and a men-
tor, at the home institution; (ii) campaign at home institutions to stress the relevance of return-
ing fellows and how they add value to the institutional, national, and regional research strategy;
and (iii) design a reintegration scheme process to support fellows’ return to their home institu-
tions. During the 1999–2012 period covered by the evaluation, 27 fellows from 16 different
countries, mainly from Africa with a minority from Asia and Latin America, participated in
the programme. At the time of submission of this manuscript, an additional 16 fellows have
been trained in 10 host institutions, including three PDPs and two research institutions (one of
them located in Zimbabwe). The programme has expanded to a total of 42 current selected fel-
lows, 18 host organisations, and now covers eight different disease areas. More qualified female
candidates have been encouraged in the call description and during the application period to
enter the selection process in order to adjust the gender balance in the long term.
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In the course of the evaluation, selected fellows raised both during interviews and alumni
meetings that any form of internationally recognized academic accreditation of the CDF would
add to career prospects. Also, on sub-Saharan African institution is not sending candidates due
to lack of academic recognition and instead send their staff for academic degrees. The issue of
accreditation remains unresolved for the moment as the programme will need to make efforts
to meet the lifelong learning requirements set out in the Bologna Declaration for acquisition of
credits in non-higher education contexts [21].
Subsequent to the evaluation period, and in line with the evaluation’s recommendations, the
new phase of the CDF programme was jointly launched in 2014 by TDR and the European &
Developing Countries Clinical Trials Partnership (EDCTP), which signed a partnership agree-
ment in March 2014 for a clinical development fellowship allowing both to be, “more efficient
with the funding provided by our donors” [22]. Beginning this year, an additional 25 fellows
per year will be placed at some 20 high-level product development organisations [23, 24]
through this partnership. We look forward to the clinical research collaborations and networks
that will emerge from this endeavour.
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